Stephen Marino

Title: The Innovative Contributions of Stephen Marino

Introduction

Stephen Marino is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the development of therapies targeting various blood-related disorders. With a total of 9 patents to his name, Marino's work has the potential to impact the treatment of serious medical conditions.

Latest Patents

One of Marino's latest patents involves a chimeric antigen receptor (CAR) and CAR-T cells that bind to B Cell Maturation Antigen (BCMA). This invention includes an isolated chimeric antigen receptor polypeptide that comprises an extracellular antigen-binding domain. The CAR is designed to bind to specific epitopes of human BCMA, which is crucial for treating diseases associated with pathogenic B cells, such as multiple myeloma and non-Hodgkin's lymphoma. Another notable patent focuses on extracorporeal devices for treating diseases linked to anti-neutrophil cytoplasmic antibodies (ANCAs). This blood treatment device is engineered to remove ANCAs from the blood or plasma, utilizing a matrix that includes a monomeric form of proteinase 3 (PR3).

Career Highlights

Throughout his career, Stephen Marino has worked with esteemed institutions, including the Max Delbrück Center for Molecular Medicine in the Helmholtz Association. His research and innovations have positioned him as a key figure in the medical technology landscape.

Collaborations

Marino has collaborated with notable colleagues such as Felix Oden and Oliver Daumke, contributing to the advancement of medical research and technology.

Conclusion

Stephen Marino's innovative work in the field of medical technology showcases his dedication to improving treatment options for patients with serious health conditions. His patents reflect a commitment to advancing medical science and enhancing patient care.